Cargando…
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
A new therapeutic class of oral agents firstly used for the treatment of type 2 diabetes mellitus is represented by gliflozines or sodium-glucose co-transporter 2 (SGLT2) inhibitors. SGLT2 inhibitors might be effective alone or in combination with any other drugs. This therapeutic class currently in...
Autores principales: | Mascolo, Annamaria, Di Napoli, Raffaella, Balzano, Nunzia, Cappetta, Donato, Urbanek, Konrad, De Angelis, Antonella, Scisciola, Lucia, Di Meo, Irene, Sullo, Maria Giuseppa, Rafaniello, Concetta, Sportiello, Liberata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532622/ https://www.ncbi.nlm.nih.gov/pubmed/36211584 http://dx.doi.org/10.3389/fcvm.2022.1010693 |
Ejemplares similares
-
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
por: Ruggiero, Rosanna, et al.
Publicado: (2022) -
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
por: Sportiello, Liberata, et al.
Publicado: (2023) -
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
por: Mascolo, Annamaria, et al.
Publicado: (2023) -
Complete resistance after maximal dose of rocuronium
por: Capuano, Annalisa, et al.
Publicado: (2015) -
Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
por: Sessa, Maurizio, et al.
Publicado: (2018)